CBAV Share Price | Clínica Baviera SA Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.1 k

Shareholding (Mar 2010)

FII

0.00%

Held by 0 FIIs

DII

100.00%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Debt company with Weak Long Term Fundamental Strength

The company is Net-Debt Free

With ROE of 36.03%, it has a Very Expensive valuation with a 7.69 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

EUR 930 Million ()

P/E

21.00

Industry P/E

Dividend Yield

2.75%

Debt Equity

-0.59

Return on Equity

41.95%

Price to Book

8.33

Revenue and Profits:

Net Sales:

83 Million

(Quarterly Results - Jun 2026)

Net Profit:

12 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

58.86%

6 Months

68.48%

1 Year

102.18%

2 Years

212.36%

3 Years

153.88%

4 Years

270.67%

5 Years

485.26%

Clínica Baviera SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

20.27%

EBIT Growth (5y)

24.71%

EBIT to Interest (avg)

59.43

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.43

Sales to Capital Employed (avg)

2.41

Tax Ratio

27.75%

Dividend Payout Ratio

48.42%

Pledged Shares

Institutional Holding

0.12%

ROCE (avg)

116.33%

ROE (avg)

40.00%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.69

EV to EBIT

14.52

EV to EBITDA

10.35

EV to Capital Employed

13.44

EV to Sales

2.91

PEG Ratio

2.80

Dividend Yield

2.68%

ROCE (Latest)

92.58%

ROE (Latest)

36.03%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2010

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 11.41% vs 14.44% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 21.21% vs -14.66% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "83.00",
          "val2": "74.50",
          "chgp": "11.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.20",
          "val2": "20.40",
          "chgp": "18.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.30",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.00",
          "val2": "9.90",
          "chgp": "21.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "209.10%",
          "val2": "197.20%",
          "chgp": "1.19%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14.93% vs 16.76% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.38% vs 11.99% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "301.80",
          "val2": "262.60",
          "chgp": "14.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "106.10",
          "val2": "92.80",
          "chgp": "14.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "1.20",
          "chgp": "91.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "42.90",
          "val2": "41.10",
          "chgp": "4.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "272.50%",
          "val2": "273.90%",
          "chgp": "-0.14%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]